Avestar Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Avestar Capital’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,551	Closed	-$415K	–	430
2021 Q3	$415K	Hold	5,551	–	–	0.05%	294
2021 Q2	$513K	Sell	5,551 -1,990	-26%	-$169K	0.07%	261
2021 Q1	$691K	Buy	7,541 +4,481	+146%	+$444K	0.15%	141
2020 Q4	$285K	Sell	3,060 -14,573	-83%	-$1.16M	0.08%	221
2020 Q3	$1.22M	Buy	+17,633	New	+$1.03M	0.4%	43

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avestar Capital's ARKG Position: Q4 2021 in Review

Avestar Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 5,551 shares — an estimated $415K sold.

Avestar Capital first reported a position in ARKG in Q3 2020 and held it in 5 quarters. The position peaked at $1.22M in Q3 2020. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

Avestar Capital reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
Avestar Capital sold 5,551 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $415K.
Avestar Capital first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 5 quarters.
Avestar Capital's ARK Genomic Revolution ETF position peaked at $1.22M in Q3 2020.
460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Avestar Capital's 13F filing for Q4 2021, filed 1 Feb 2022.